Background: Though functional dyspepsia (FD) is often a diagnosis of exclusion, whether minor mucosal gut pathology represents organic disease or FD, it still remains controversial. Aims and Objectives: The present study has been conducted to determine the accuracy of symptom based diagnosis of FD based on Rome III diagnostic criteria in a tertiary care center. Materials and Methods: Total 140 patients aged between 18-55 years of both sexes with upper abdominal symptoms without known or post investigational organic diseases, were included in this study. Patients fulfilling the Rome III criteria were diagnosed as FD and undergone upper GI endoscopy (UGIE). Those devoid of organic lesions were confirmed as 'true FD'. Results: Out of 140 study patients, 100 patients fulfilled Rome III criteria (clinical FD) out of which 77 were confirmed as 'true FD' after UGIE with an accuracy of 83.57 %. Conclusion: Rome III clinical criteria can be applied to diagnose FD in a tertiary care center with some limitations. The authors suggest some modification of Rome III criteria.
INTRODUCTION
Dyspepsia and gastrointestinal reflux diseases (GERD) are very prevalent throughout the world. [1] [2] [3] [4] [5] Though they are often overlapping, an well accepted definition of dyspepsia is lacking. It is often vaguely defined as upper abdominal pain or discomfort with or without other gastrointestinal symptoms such as nausea, belching, vomiting etc. [6] [7] [8] The most common dyspepsia is the functional dyspepsia (FD).
According to the Rome III criteria, functional gastrointestinal disorder (FGID) has been categorized into the following major groups: i) Category A (functional esophageal), ii) Category B (functional gastroduodenal), iii) Category C (functional bowel), iv) Category D (functional abdominal pain syndrome), v) Category E (functional gall bladder and sphincter of Oddi disorder), vi) Category F (functional anorectal disorder), vii) Category G (childhood functional GI disorder: Infant/ Toddler), viii) Category H (childhood functional GI disorder: Child/ Adolescent).
Out of these categories, functional dyspepsia (FD) falls under the category B (B1 subtype) i.e. functional gastroduodenal disorders subgroup of FGID.
Functional Dyspepsia (FD) is a highly prevalent (20-30%) disorder with large geographic variation. It is defined as persistent or recurrent pain or discomfort centered in the 
MATERIALS AND METHODS
After approval from institutional ethical committee this study was conducted in Nilratan Sircar Medical College and Hospital, a tertiary care medical college hospital in eastern India. Total 140 patients aged between 18-55 years of both sexes with upper abdominal symptoms without known or post investigational organic diseases, attending the Outpatient Department (OPD) of General Medicine were selected as study population.
Any patient having age > 55 years or < 18 years at symptom onset, endoscopic evidence of structural gastrointestinal diseases, patients with red flag signs like gastrointestinal bleeding, abdominal pain awakening the patients at night, significant weight loss or fever; family history of upper gastrointestinal malignancy, recurrent vomiting, dysphagia or patients with upper gastrointestinal symptoms resulting from some chronic heart, kidney or liver diseases were excluded from this study.
Total 140 patients meeting the inclusion criteria and does not falling into the exclusion criteria at the time of first visit to General Medicine OPD were included in this study. After obtaining written informed consent of the patients, detailed history was taken regarding patient profile and symptoms including bothersome post-prandial fullness, early satiety, epigastric pain, epigastric burning sensation etc. to rule out organic causes and chronic ailments that can produce chronic upper abdominal symptoms. Thorough clinical examinations were done to rule out apparent organic anomalies. They were also given a set of questionnaire which was to be answered promptly. Thus the patients fulfilling the Rome III criteria were diagnosed as FD. Now, these clinical FD patients were advised for various laboratory investigations to exclude chronic diseases and organic causes. These included biochemical parameters, upper abdominal ultrasonography etc. and most importantly, immediate upper GI endoscopy (UGIE) with or without biopsy, the gold standard test to differentiate between FD and organic dyspepsia. At the same time, appropriate treatment for organic dyspepsia (Proton Pump Inhibitors or PPIs) was given to all the patients of study population (i.e., both FD and organic dyspepsia) for at least 8 weeks and observed whether the symptoms of either FD patients or organic disease patients persist or not. There would be persistence of symptoms if organic dyspepsia was coexistent with FD.
Statstical analysis
Data were entered in Microsoft Excel spread sheet and analyzed using SPSS software version 18.0 (SPSS Inc., Chicago, Illinois, USA) with appropriate statistical techniques. Numerical data were presented as percentages. Categorical data were compared using Chi-square test.
A p value of less than 0.05 was considered as statistically 'significant' (p < 0.05).
RESULTS
A total of 140 patients aged between 18-55 years of both sexes with upper abdominal symptoms without known or post investigational organic diseases were included in this study. Among these 140 patients, 100 patients who fulfilled the Rome III criteria and thus were clinically diagnosed as FD, undergone upper GI endoscopy (taken as 'Gold standard' in this study) revealing that only 77 patients truly suffered from FD and the rest 23 patients were actually suffering from organic dyspepsia. Out of these 23 patients, 11 had peptic ulcer disease (PUD), 9 had erosive gastritis (EG), 1 had both PUD and EG,1 had both EG and varix and only 1 had gastric malignancy. Negative Predictive value (NPV) = 100% with 95% CI: 91.11-100.00 %.
However, as the sample sizes in positive and negative groups do not reflect the real prevalence of the disease, PPV and NPV should be ignored.
So, it can be said that Rome III criteria is a valid clinical criteria to diagnose FD with an accuracy of 83.57 %.
DISCUSSION
Functional dyspepsia (FD) is one of the common health problems due its high prevalence in the general population. Rome III consensus divided it into meal related symptoms and meal unrelated symptoms which were named as postprandial distress syndrome (PDS) and epigastric pain syndrome (EPS) respectively. The applicability of this subdivision in the diagnosis and management of FD in a tertiary care hospital were our clinical research area. In this study, we found that Rome III clinical criteria were 9 Rome III criteria could not be applied on 62.7% of PDS and 61.3% of EPS patients as the onset of symptoms were within 6 months of diagnosis (4.6 ± 0.4 months for PDS and 4.6 ± 0.5 months for EPS patients). They concluded that Rome III criteria is unable to identify a large group of patients of FD because of earlier presentation for medical care and emphasized the need to reduce the duration of symptom onset from 6 months to a lesser value, at least for the Japanese population. 9 However, Reisswitz PSV et al showed the validity of Rome III diagnostic questionnaire in adequately evaluating FD in Portuguese population with 5.3 % of control population and 91.2 % of dyspeptic patients having FD. 10 Abid S et al tried to evaluate Rome III questionnaires for diagnosis of FD and to clarify whether it can differentiate between EPS and PDS.
11 70 % (191 out of 272) of the study population fulfilled the definition of FD as per Rome III criteria with 57 % having EPS, 9 % having PDS, 29 % having overlap between EPS and PDS and the rest 5 % being indeterminate. Subsequent upper GI endoscopy revealed that only 71 % (136/191) of these clinical FD patients were 'true FD' (77 % in present study). So, roughly one third of patients fulfilling Rome III criteria had organic diseases and one third of confirmed FD patients did not fall into either of EPS or PDS categories.
11
Documented literature has also provided evidence of significant overlap between presenting symptoms of FD. In fact, considerable portion of patients may not be classifiable at all. 12 Therefore, there is a need for further redefining of Rome III subgroups.
Park JM et al evaluated the pattern of FGIDs both in primary care clinics and tertiary care hospitals and assessed problems in diagnosing the FGIDs by Rome III criteria on Korean population. 13 In primary clinics, 44.9 % patients were diagnosed as having FGIDs with 1: 3 male-female ratio, but it was 53.5 % in tertiary hospitals with 1: 2 malefemale ratio. The most common FGID was FD (46 %) followed by IBS (40.2 %) both in primary and tertiary care centre which was same as obtained previously using Rome II criteria 14 and the most common subtype of FD was PDS (same as present study) which was different from previous study using Rome II criteria 14 (again, similar to present study). Park JM et al also showed presence of more than one FGID in 51 % patients and the most common overlap was FD with IBS which was in concordance with previous studies.
15, 16
Lee YY et al surveyed Rome III criteria among ethnic Malays in a primary care center and found 84.2 % of clinical FD patients having 'true FD' with EPS being most common symptom (68.8 %) and rest having overlapping symptoms with PDS (31.2 %). 17 In the present study, along with the applicability of Rome III criteria in diagnosis of FD, we have also tried to evaluate the effect of some other parameters like age, gender, occupation, marital status, education etc. on FD. Out of 77 true FD patients 40.26 % were male and 59.74 % were female, so, male-female ratio was 2: 3. Though most population based studies showed that frequency of uninvestigated dyspepsia (UD) was not related to gender, several studies in different population have noted a consistent female predominance with dyspepsia. [18] [19] [20] [21] [22] Female gender was found to be the only independent risk factor of FD among 2865 Taiwanese health check attendees. 21 In one population based study in Australia, female adults significantly outnumbered males in most GI disorders including FD. 23 One exception with male preponderance (M: F = 2:1) of UD was found in one Japanese study by Kawamura A et al. 24 Dyspepsia does not appear to be related to any particular age group. Most of the studies being done in patients above 18 years of age, significant data about dyspepsia among children is lacking and it is a common disorder when it is considered as upper abdominal pain. 25 In spite of this, different studies have showed a particular trend of FD among different age group. Peak FD was found to be 41-50 years among Chinese population. 26, 27 It is > 40 years in Indian population. 28 Peak prevalence of UD has been found to be 45-54 years in Canadian survey. 29 
Britain
18 and Taiwan 19 show a decreasing trend of FD with age. In this study, most of the patients were in 30-39 years age group (42.86 %) followed by 40-49 years (27.27 %).
In some studies, relations of FD with socioeconomic condition have been found. Drossman DA et al showed a strong relationship between lower household income and larger household membership with increased FGID including FD. 30 Similarly in a British study, Moayyedi P et al found that rented accommodation without central heating, low income, sharing of same bed with sibling were predictors of UD in adults. 31 We had only included marriage, occupation and literacy as our socioeconomic study parameters. Similar to Lee YY et al, 17 our study showed higher prevalence of FD among married persons (80.52 %). We had demonstrated higher frequency of FD among housewives than office workers or people of other occupation. Total 70.13 % were literate.
In this study, patients diagnosed as 'true FD' after upper GI endoscopy, were prescribed with PPIs for 8 weeks and symptoms were improved in a statistically significant manner (p value = 0.009). Though previous studies have shown that EPS may be alleviated by using PPIs 32, 33 and symptoms of early satiety related to PDS improve using prokinetic drugs, 34, 35 there is no study in the literature that have tested the effect of PPI or prokinetics in Rome III based subgroups of patients with FD. In fact, treatment of a syndrome based solely on symptoms has not yet provided satisfactory results.
34-36

Limitation of study
Our study suffered from several limitations. Firstly, the study population only included those patients attending tertiary care hospital. So, applicability of this study to general population is questionable. Secondly, preponderance of FD among female patients may be attributed to the fact that most of the patients attending medicine OPD were female. Thirdly, we found epigastric pain as most common symptom but most common FD subgroup was PDS because in most of the cases epigastric pain was associated with post-prandial fullness and early satiety. Fourthly, this single center study with small population may not reflect actual scenario on a larger scale. Fifthly, this study did not show the usefulness of Rome III criteria in the FD management.
CONCLUSION
We conclude that, a Rome III clinical criterion is applicable to diagnose FD in a tertiary care hospital. However, there are limitations as it cannot diagnose 100 % FD patients truly and also a number of FD patients cannot be subcategorized into either of PDS or EPS because of presence of features of both of these. So, a third subgroup of mixed pattern should be included along with EPS and PDS; and if possible, time frame of the diagnostic criteria should be reconsidered for the applicability to all the ethnic groups.
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